Sionna Therapeutics (SION) Stock Price, Quote, News & History | Benzinga

Sionna Therapeutics Inc (SION) Stock Price, Quote, News & History

SIONNASDAQ

Trade with Public

Trade with Public

$6.46

-0.08-1.22%

At close: Aug 14, 5:00 PM EST

$6.35

-0.11-1.7%

After Hours: Aug 14, 7:57 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$6.24

Close

$6.46

Volume / Avg.

2.88M / 1.53M

Day Range

$6.15 - $6.66

52 Wk Range

4.01 - 54.97

Market Cap

$287.10M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

15.06%

Days to Cover

6.79

Recent Sionna Therapeutics, Inc. News

Sionna Therapeutics Discontinues Cystic Fibrosis Drug Following Unfavorable Data Data, Stock Tanks

Sionna Therapeutics topline clinical data for cystic fibrosis programs disappoints, opting to discontinue its SION-719 candidate.

Vandana Singh

Crude Oil Surges 3%; Sionna Therapeutics Shares Plunge

US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National Energy Services up 16% on strong earnings.

Avi Kapoor

US Stocks Edge Lower; Monday.Com Shares Tumble After Q2 Results

Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dropped 0.9%. Monday.com shares fell 10%.

Avi Kapoor

This UFP Industries Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday

Top Wall Street analysts changed outlook on top names. Check analyst ratings page for full changes. See other analysts' views on UFPI, TWST, BMA, and PAC.

Avi Kapoor

This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Citations for AMAT, BMEA, ACRS, KALU, SION.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-75.92M

Investing Cash Flow (TTM)

91.98M

Financing Cash Flow (TTM)

6.28M

Free Cash Flow (TTM)

-76.21M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

22.34M

Analyst Trends and Forecast

0

0

0

0

Feb

2

Mar

2

Apr

3

May

1

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$90.01M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.11

Earnings Yield % (TTM)

-32.87%

Earnings Yield % (FWD)

-40.37%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$5.88

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$63.32M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$6.24

Close

$6.46

Volume / Avg.

2.88M / 1.53M

Day Range

$6.15 - $6.66

52 Wk Range

4.01 - 54.97

Market Cap

$287.10M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

22

Short Interest

15.06%

Days to Cover

6.79

About

Sector

Health Care

Industry

Biotechnology

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis tran...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sionna Therapeutics (SION) stock?

A

You can purchase shares of Sionna Therapeutics (NASDAQ:SION) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sionna Therapeutics (SION) competitors?

A

Other companies in Sionna Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Sionna Therapeutics (SION) stock?

A

Sionna Therapeutics has a consensus price target of $44.13.

Q

What is the current price for Sionna Therapeutics (SION)?

A

The stock price for Sionna Therapeutics (NASDAQ: SION) is $6.35 last updated August 14, 2026 at 7:57 PM EDT.

Q

Does Sionna Therapeutics (SION) pay a dividend?

A

There are no upcoming dividends for Sionna Therapeutics.

Q

When is Sionna Therapeutics (NASDAQ:SION) reporting earnings?

A

Sionna Therapeutics does not have any upcoming earnings scheduled.

Q

Is Sionna Therapeutics (SION) going to split?

A

There is no upcoming split for Sionna Therapeutics.

Q

What sector and industry does Sionna Therapeutics (SION) operate in?

A

Sionna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.